Abstract Body

Despite the success of cART, HIV-1 persists in a latent state in patients. Persistence is a consequence of proviral integration. LEDGF/p75 is the pivotal chromatin tethering factor targeting HIV integration into active transcription units through its interaction with HIV-1 integrase. We investigated the role of integration site selection in the establishment of HIV persistence employing LEDGF/p75 knockout cells and LEDGINs interfering with the LEDGF/p75-IN interplay.

To evaluate whether the reactivation potential of the quiescent proviral reservoir is dependent on integration site selection during reservoir establishment, LEDGF/p75 WT and KD/KO cell lines were infected with HIVNL4.3-tCD34 or a double reporter virus that allows direct visualization of the quiescent pool. Formation of the quiescent pool in primary CD4+ T-cells was studied in the presence and absence of LEDGINs during primary infection. Cells were reseeded 2 weeks post infection and reactivation by different latency reversing agents was monitored by FACS analysis. Integration sites were amplified using LM-PCR.

LEDGF/p75 depletion hampers HIV-1 reactivation by latency reversing agents in cell culture. LEDGIN-mediated inhibition of the LEDGF/p75-IN interaction shifts integration out of transcription units and relocalizes the 3D nuclear location of the provirus away from the nuclear rim, comparable with previous observations for LEDGF/p75 depletion. Interestingly, LEDGIN treatment increases the relative fraction of quiescent provirus and blocks HIV reactivation from latency, both in a dose-dependent manner (IC50 CX014442 ≈ 7.24 μM). This approach may represent a viable alternative to the shock-and-kill strategies for functional eradication of HIV in patients as LEDGIN treatment apparently succeeds in rendering almost 100% of the virus into a quiescent state refractory to reactivation.

LEDGF/p75 determines the integration site pattern of HIV. The presented data in cell lines and in primary cells support our hypothesis that LEDGINs, small molecules that inhibit the interaction between integrase and LEDGF/p75, retarget integration away from the nuclear rim and in genomic regions that are less sensitive to reactivation. If further corroborated in clinical trials, this strategy may pave the way towards a functional cure. Pushing the provirus into quiescence could drive the basic reproduction number of HIV below a threshold required for sustained infection even after treatment interruption.